ID21450A - S-oksida dan s,s-dioksida tetrahidrotiopiran pheniloksazolidinon - Google Patents

S-oksida dan s,s-dioksida tetrahidrotiopiran pheniloksazolidinon

Info

Publication number
ID21450A
ID21450A IDP981545A ID981545A ID21450A ID 21450 A ID21450 A ID 21450A ID P981545 A IDP981545 A ID P981545A ID 981545 A ID981545 A ID 981545A ID 21450 A ID21450 A ID 21450A
Authority
ID
Indonesia
Prior art keywords
phenyloksazolidinone
hydrotiopyrane
oxidide
dioxide
dichloromethyl
Prior art date
Application number
IDP981545A
Other languages
English (en)
Inventor
Toni-Jo Poel
Joseph P Martin Jr
Michael R Barbachyn
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of ID21450A publication Critical patent/ID21450A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Catalysts (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
IDP981545A 1997-12-05 1998-11-26 S-oksida dan s,s-dioksida tetrahidrotiopiran pheniloksazolidinon ID21450A (id)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6783097P 1997-12-05 1997-12-05
US8949898P 1998-06-16 1998-06-16
US10018598P 1998-09-14 1998-09-14

Publications (1)

Publication Number Publication Date
ID21450A true ID21450A (id) 1999-06-10

Family

ID=27371238

Family Applications (1)

Application Number Title Priority Date Filing Date
IDP981545A ID21450A (id) 1997-12-05 1998-11-26 S-oksida dan s,s-dioksida tetrahidrotiopiran pheniloksazolidinon

Country Status (21)

Country Link
US (2) US6083967A (id)
EP (2) EP1036074B1 (id)
JP (1) JP2001525408A (id)
KR (1) KR20010032782A (id)
CN (2) CN1154645C (id)
AT (1) ATE231859T1 (id)
AU (2) AU752454B2 (id)
BR (1) BR9814897A (id)
CA (1) CA2309026A1 (id)
DE (1) DE69811117T2 (id)
DK (1) DK1036074T3 (id)
ES (1) ES2191985T3 (id)
HU (1) HUP0100558A3 (id)
ID (1) ID21450A (id)
NO (1) NO316447B1 (id)
NZ (1) NZ504930A (id)
PL (1) PL340835A1 (id)
SI (1) SI1036074T1 (id)
SK (1) SK7692000A3 (id)
TW (2) TW553942B (id)
WO (1) WO1999029688A1 (id)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6511468B1 (en) * 1997-10-17 2003-01-28 Micro Therapeutics, Inc. Device and method for controlling injection of liquid embolic composition
KR20010052615A (ko) 1998-06-05 2001-06-25 다비드 에 질레스 옥사졸리디논 유도체, 이것의 제조 방법 및 이것을함유하는 약학 조성물
MY120189A (en) 1999-11-04 2005-09-30 Upjohn Co Sultam and sultone derived oxazolidinones
GB9928568D0 (en) 1999-12-03 2000-02-02 Zeneca Ltd Chemical compounds
DE19962924A1 (de) 1999-12-24 2001-07-05 Bayer Ag Substituierte Oxazolidinone und ihre Verwendung
GB0009803D0 (en) 2000-04-25 2000-06-07 Astrazeneca Ab Chemical compounds
DE10129725A1 (de) 2001-06-20 2003-01-02 Bayer Ag Kombinationstherapie substituierter Oxazolidinone
US7141588B2 (en) 2002-02-25 2006-11-28 Pfizer, Inc. N-aryl-2-oxazolidinone-5-carboxamides and their derivatives
AR038536A1 (es) 2002-02-25 2005-01-19 Upjohn Co N-aril-2-oxazolidinona-5- carboxamidas y sus derivados
WO2004014897A1 (en) 2002-08-12 2004-02-19 Pharmacia & Upjohn Company Llc N-aryl-2-oxazolidinones and their derivatives
WO2004045616A1 (en) 2002-11-21 2004-06-03 Pharmacia & Upjohn Company Llc N-(4-(piperazin-1-yl)-phenyl-2-oxazolidinone-5-carboxamide derivates and related compounds as antibacterial agents
DE10300111A1 (de) 2003-01-07 2004-07-15 Bayer Healthcare Ag Verfahren zur Herstellung von 5-Chlor-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophencarboxamid
US7304050B2 (en) 2003-09-16 2007-12-04 Pfizer Inc. Antibacterial agents
DE10355461A1 (de) 2003-11-27 2005-06-23 Bayer Healthcare Ag Verfahren zur Herstellung einer festen, oral applizierbaren pharmazeutischen Zusammensetzung
DE102004062475A1 (de) * 2004-12-24 2006-07-06 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit modifizierter Freisetzung
EP1685841A1 (en) 2005-01-31 2006-08-02 Bayer Health Care Aktiengesellschaft Prevention and treatment of thromboembolic disorders
DE102005045518A1 (de) 2005-09-23 2007-03-29 Bayer Healthcare Ag 2-Aminoethoxyessigsäure-Derivate und ihre Verwendung
DE102005047558A1 (de) * 2005-10-04 2008-02-07 Bayer Healthcare Ag Kombinationstherapie substituierter Oxazolidinone zur Prophylaxe und Behandlung von cerebralen Durchblutungsstörungen
PT1934208E (pt) 2005-10-04 2011-06-01 Bayer Schering Pharma Ag Nova forma polimorfa de 5-cloro-n-({(5s)-2-oxo-3-[4-(3- oxo-4-morfolinil)-fenil]-1,3-oxazolidin-5-il}-metil)-2- tiofenocarboxamida
DE102005047561A1 (de) 2005-10-04 2007-04-05 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit schneller Wirkstofffreisetzung
CN102262066A (zh) * 2011-06-16 2011-11-30 董理 一种检测单胺氧化酶含量的方法和试剂盒
CN104610479B (zh) * 2013-11-05 2017-03-29 中国石油化工股份有限公司 用于乙烯聚合的负载化茂金属催化剂及其制备方法和应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1302422C (en) * 1986-09-03 1992-06-02 Margherita Strolin-Benedetti 5-aminoethyloxazolidin-2-one derivatives, process for the preparation thereofand their therapeutic use
US4885154A (en) * 1988-03-01 1989-12-05 Alza Corporation Method for reducing sensitization or irritation in transdermal drug delivery and means therefor
US4948801A (en) * 1988-07-29 1990-08-14 E. I. Du Pont De Nemours And Company Aminomethyloxooxazolidinyl arylbenzene derivatives useful as antibacterial agents
US5130316A (en) * 1988-07-29 1992-07-14 Du Pont Merck Pharmaceutical Company Aminomethyloxooxazlidinyl arylbenzene derivatives useful as antibacterial agents
US5254577A (en) * 1988-07-29 1993-10-19 The Du Pont Merck Pharmaceutical Company Aminomethyloxooxazolidinyl arylbenzene derivatives useful as antibacterial agents
JP2669579B2 (ja) * 1991-10-23 1997-10-29 エーザイ株式会社 オキサゾリドン誘導体
AU667198B2 (en) * 1991-11-01 1996-03-14 Pharmacia & Upjohn Company Substituted aryl- and heteroarylphenyloxazolidinones useful as antibacterial agents
JP3558088B2 (ja) * 1992-12-08 2004-08-25 ファルマシア・アンド・アップジョン・カンパニー トロポン−置換のフェニルオキサゾリジノン抗菌剤
CA2228647A1 (en) * 1995-09-01 1997-03-13 Pharmacia & Upjohn Company Phenyloxazolidinones having a c-c bond to 4-8 membered heterocyclic rings
GB9702213D0 (en) * 1996-02-24 1997-03-26 Zeneca Ltd Chemical compounds

Also Published As

Publication number Publication date
SI1036074T1 (en) 2003-08-31
JP2001525408A (ja) 2001-12-11
WO1999029688A1 (en) 1999-06-17
DE69811117D1 (de) 2003-03-06
SK7692000A3 (en) 2001-03-12
CN1154645C (zh) 2004-06-23
NO316447B1 (no) 2004-01-26
HUP0100558A3 (en) 2002-08-28
AU1796899A (en) 1999-06-28
NO20002834D0 (no) 2000-06-02
KR20010032782A (ko) 2001-04-25
DE69811117T2 (de) 2003-07-17
EP1036074A1 (en) 2000-09-20
ATE231859T1 (de) 2003-02-15
US6083967A (en) 2000-07-04
NZ504930A (en) 2002-05-31
NO20002834L (no) 2000-07-21
AU2002301031B2 (en) 2005-08-25
CN1532535A (zh) 2004-09-29
PL340835A1 (en) 2001-02-26
TW200307673A (en) 2003-12-16
EP1254906A1 (en) 2002-11-06
ES2191985T3 (es) 2003-09-16
CN1278817A (zh) 2001-01-03
TW553942B (en) 2003-09-21
HUP0100558A2 (hu) 2002-05-29
BR9814897A (pt) 2000-10-03
DK1036074T3 (da) 2003-06-23
CA2309026A1 (en) 1999-06-17
TWI239331B (en) 2005-09-11
EP1036074B1 (en) 2003-01-29
AU752454B2 (en) 2002-09-19
HK1032970A1 (en) 2001-08-10
US6265178B1 (en) 2001-07-24

Similar Documents

Publication Publication Date Title
DK1036074T3 (da) S-Oxid-tetrahydrothiopyran-phenyloxazolidinoner
DE69821985D1 (de) Ortho-anthranilamide derivate als antikoagulantien
PT918776E (pt) Sintese total de acilfulvenos antitumorais
TR199901473T2 (xx) Ha�ere �ld�r�c� 1-arilpirazoller
ES2136887T3 (es) Derivados antifungicos de sordaridina.
DE3767778D1 (de) Entzuendung verhindernde und allergie heilende mittel.
ATE280767T1 (de) Antidiabetische thiazolidindione und ihre herstellung
ATE141272T1 (de) Beta-lactam-verbindungen und ihre herstellung
BR0115996A (pt) Sulfamidotienopirimidinas
DK0841327T3 (da) Triazolantisvampemiddel
DK0623131T3 (da) Alkylderivater af trazodon med CNS-aktivitet
ATE245147T1 (de) Substituierte aminochinazolinon (thion) derivate
DK0812835T3 (da) Optisk aktive thiazolidinonderivater
DE69932269D1 (de) Herstellung optisch aktiver Cyclohexylphenylglykolsäureester
TR200001122T2 (tr) Farmasötikler olarak bifenil türevleri.
BR9902096A (pt) Pitazóis.
DK0963998T3 (da) Azasteroidforbindelse til behandling eller prævention af prostatacancer
ES2077697T3 (es) Derivados de 1-fenoxicarbonil-2-pirrolidinona y agentes nootropicos.
ATE556075T1 (de) Triazoquinolone-derivate als pestizide
FI912499A0 (fi) Pyrido/3,4-b/pyrrolo/1,2-e//1,4,5/ oxadiazepiner och daermed naerbeslaektade analoger, foerfarande foer deras framstaellning och deras anvaendning som laekemedel.
DK1140932T3 (da) Derivater af benzo-1,8-naphtyridin
ATE74604T1 (de) Substituierte pyrimidochinoxaline.